DARE - Dare Bioscience, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Dare Bioscience, Inc.
Dare Bioscience Inc is a healthcare company. The company develops and commercializes products in women's reproductive health. Its segment includes spectrum of categories like: contraception, vaginal health, pain and fertility.
IPO Date: April 10, 2014
Sector: Healthcare
Industry: Biotech
Market Cap: $15.43M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.07 | 4.43%
Avg Daily Range (30 D): $0.06 | 5.14%
Avg Daily Range (90 D): $0.08 | 4.68%
Institutional Daily Volume
Avg Daily Volume: 1.01M
Avg Daily Volume (30 D): .69M
Avg Daily Volume (90 D): .4M
Trade Size
Avg Trade Size (Sh.): 420
Avg Trade Size (Sh.) (30 D): 258
Avg Trade Size (Sh.) (90 D): 228
Institutional Trades
Total Institutional Trades: 10
Avg Institutional Trade: $1.13M
Avg Institutional Trade (30 D): $.69M
Avg Institutional Trade (90 D): $.69M
Avg Institutional Trade Volume: .6M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.48M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 836.09K
 
News
Aug 14, 2025 @ 8:18 PM
Daré Bioscience Posts Narrower Q2 Loss
Source: Jesterai
Jul 21, 2025 @ 5:47 PM
UPDATE - Daré Bioscience to Host August 6 Webin...
Source: Daré Bioscience, Inc.
Aug 13, 2024 @ 12:00 PM
Daré Bioscience Announces Publication in The Jo...
Source: N/A
Jul 19, 2024 @ 6:09 PM
Dare Bioscience regains Nasdaq compliance with bid...
Source: Natashya Angelica
Jul 19, 2024 @ 12:03 PM
Daré Bioscience Regains Compliance with Nasdaq ...
Source: N/A
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.71 $-.2 $-.21
Diluted EPS $-.71 $-.2 $-.21
Revenue $1.37M $.19M $.15M
Gross Profit $-.13M $-.09M
Net Income / Loss $-10.99M $-2.98M $-3M
Operating Income / Loss $-11.11M $-2.97M $-3M
Cost of Revenue $.86M $.32M $.24M
Net Cash Flow $7.58M $-12.05M $-.04M
PE Ratio    
Splits
Jul 01, 2024 1:12